Pier Capital’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Other funds holding PTGX
Pier Capital's PTGX Position: Q3 2026 in Review
Pier Capital opened a new position in Protagonist Therapeutics (PTGX) in Q3 2026: 57,392 shares worth $8.09M. The stake represents 1.17% of the portfolio and ranks #28 among its holdings.
379 funds tracked by Wall St. Rank hold PTGX as of Q3 2026.
- Pier Capital held 57,392 shares of Protagonist Therapeutics worth $8.09M as of Q3 2026.
- Protagonist Therapeutics was a new Pier Capital position in Q3 2026.
- Protagonist Therapeutics made up 1.17% of Pier Capital's portfolio in Q3 2026, its #28 holding.
- 379 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2026.
Based on Pier Capital's 13F filing for Q3 2026, filed 13 Nov 2026.